Insulet Corporation (PODD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:17PM EDT. Market open.
| Previous close | 164.17 |
| Open | 163.32 |
| Bid | 166.12 x 200 |
| Ask | 166.63 x 200 |
| Day's range | 162.99 - 168.38 |
| 52-week range | 125.82 - 335.91 |
| Volume | |
| Avg. volume | 869,170 |
| Market cap | 11.668B |
| Beta (5Y monthly) | 1.00 |
| PE ratio (TTM) | 56.68 |
| EPS (TTM) | 2.94 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 236.83 |
ZacksWhy Investors Need to Take Advantage of These 2 Medical Stocks Now
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
ZacksInsulet (PODD) Awaits Q1 Earnings Release: Here's What to Expect
Strong global new customer starts fueled by the ongoing Omnipod 5 demand are expected to significantly benefit Insulet's (PODD) first-quarter performance.
Zacks5 Large-Cap Medical Stocks to Buy Ahead of Q1 Earnings
We have narrowed our search to five S&P 500 medical stocks that are poised to beat on first-quarter earnings results.These are: HCA, UHS, LH, EW, PODD.
© 2024 Yahoo. All rights reserved.